Photodiagnosis and Photodynamic Therapy
Volume 3, Issue 4 , Pages 214-226 , December 2006

A clinical review of PDT for cutaneous malignancies

References 

  1. Geller AC, Annas GD. Epidemiology of melanoma and nonmelanoma skin cancer. Semin Oncol Nurs. 2003;19(1):2–11
  2. Stockfleth E, Sterry W. New treatment modalities for basal cell carcinoma. Recent Results Cancer Res. 2002;160:259–268
  3. Garcia-Zuazaga J, Cooper KD, Baron ED. Photodynamic therapy in dermatology: current concepts in the treatment of skin cancer. Expert Rev Anticancer Ther. 2005;5(5):791–800
  4. Humphreys TR. Skin cancer: recognition and management. Clin Cornerstone. 2001;4(1):23–32
  5. Martinez JC, Otley CC. The management of melanoma and nonmelanoma skin cancer: a review for the primary care physician. Mayo Clin Proc. 2001;76(12):1253–1265
  6. Chakrabarty A, Geisse JK. Medical therapies for non-melanoma skin cancer. Clin Dermatol. 2004;22(3):183–188
  7. Nestor MS, Gold MH, Kauvar AN, et al. The use of photodynamic therapy in dermatology: results of a consensus conference. J Drugs Dermatol. 2006;5(2):140–154
  8. Allison RR, Mota HC, Sibata CH. Clinical PD/PDT in North America: an historical review. Photodiagn Photodyn Ther. 2004;1(4):263–277
  9. Raab O. On the effect of fluorescent substances on infusoria (German). Z Biology. 1900;39:524
  10. Von Tappeiner H, Joldlbauer A. On the effect of photodynamic (fluorescent) substances on protozoa and enzymes. Arch Klin Med. 1904;80:427–487
  11. Von Tappeiner H, Joldlbauer A. The sensitizing action of fluorescent substances. An overall account of investigations on photodynamic phenomena. Leipzig: F.C.W. Vogel; 1907;
  12. Dougherty TJ. A brief history of clinical photodynamic therapy development at Roswell Park Cancer Institute. J Clin Laser Med Surg. 1996;14(5):219–221
  13. Dougherty TJ, Kaufman JE, Goldfarb A, et al. Photoradiation therapy for the treatment of malignant tumors. Cancer Res. 1978;38(8):2628–2635
  14. Allison RR, Downie GH, Cuenca R, et al. Photosensitizers in clinical PDT. Photodiagn Photodyn Ther. 2004;1(1):27–42
  15. Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J Natl Cancer Inst. 1998;90(12):889–905
  16. Gupta R, Browning AC, Wu K, et al. Verteporfin photodynamic therapy for the treatment of persistent subfoveal choroidal neovascularization after external beam radiotherapy: one-year results. Am J Ophthalmol. 2005;139(3):561–562
  17. Lui H, Anderson RR. Photodynamic therapy in dermatology: recent developments. Dermatol Clin. 1993;11(1):1–13
  18. Campbell SM, Gould DJ, Salter L, et al. Photodynamic therapy using meta-tetrahydroxyphenylchlorin (Foscan) for the treatment of vulval intraepithelial neoplasia. Br J Dermatol. 2004;151(5):1076–1080
  19. Mang TS, Allison R, Hewson G, et al. A phase II/III clinical study of tin ethyl etiopurpurin (Purlytin)- induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer. Cancer J Sci Am. 1998;4(6):378–384
  20. McCaw DL, Pope ER, Payne JT, et al. Treatment of canine oral squamous cell carcinomas with photodynamic therapy. Br J Cancer. 2000;82(7):1297–1299
  21. Henderson BW, Dougherty TJ. How does photodynamic therapy work?. Photochem Photobiol. 1992;55(1):145–157
  22. Glanzmann T, Hadjur C, Zellweger M, et al. Pharmacokinetics of tetra(m-hydroxyphenyl)chlorin in human plasma and individualized light dosimetry in photodynamic therapy. Photochem Photobiol. 1998;67(5):596–602
  23. Houle JM, Strong A. Clinical pharmacokinetics of verteporfin. J Clin Pharmacol. 2002;42(5):547–557
  24. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B. 1992;14(4):275–292
  25. Siddiqui MA, Perry CM, Scott LJ. Topical methyl aminolevulinate. Am J Clin Dermatol. 2004;5(2):127–137[discussion 138–40]
  26. Donnelly RF, McCarron PA, Woolfson AD. Drug delivery of aminolevulinic acid from topical formulations intended for photodynamic therapy. Photochem Photobiol. 2005;81(4):750–767
  27. Wiegell SR, Stender IM, Na R, et al. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin. Arch Dermatol. 2003;139(9):1173–1177
  28. Alexiades-Armenakas M. Laser and light technology and phototherapy. J Drugs Dermatol. 2005;4(4):514–515
  29. Alexiades-Armenakas M. Laser-mediated photodynamic therapy. Clin Dermatol. 2006;24(1):16–25
  30. Jeffes EW, McCullough JL, Weinstein GD, et al. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light. J Am Acad Dermatol. 2001;45(1):96–104
  31. Sibata CH, Colussi VC, Oleinick NL, et al. Photodynamic therapy: a new concept in medical treatment. Braz J Med Biol Res. 2000;33(8):869–880
  32. Mang T. Lasers and light sources for PDT: past, present and future. Photodiagn Photodyn Ther. 2004;1(1):43–48
  33. Brancaleon L, Moseley H. Laser and non-laser light sources for photodynamic therapy. Lasers Med Sci. 2002;17(3):173–186
  34. Juzeniene A, Juzenas P, Ma LW, et al. Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy. Lasers Med Sci. 2004;19(3):139–149
  35. Wilson BC, Patterson MS, Lilge L. Implicit and explicit dosimetry in photodynamic therapy: a new paradigm. Lasers Med Sci. 1997;12:182–199
  36. Zhu TC, Finlay JC, Hahn SM. Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy. J Photochem Photobiol B. 2005;79(3):231–241
  37. Allison RR, Mang TS, Wilson BD. Photodynamic therapy for the treatment of nonmelanomatous cutaneous malignancies. Semin Cutan Med Surg. 1998;17(2):153–163
  38. Hopper C. Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol. 2000;1:212–219
  39. Peng Q, Warloe T, Berg K, et al. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer. 1997;79(12):2282–2308
  40. Grapengiesser S, Ericson M, Gudmundsson F, et al. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol. 2002;27(6):493–497
  41. Pennington BE, Leffell DJ. Mohs micrographic surgery: established uses and emerging trends. Oncology (Williston Park). 2005;19(9):1165–1171[discussion 1171–2, 1175]
  42. Hadley G, Derry S, Moore RA. Imiquimod for actinic keratosis: systematic review and meta-analysis. J Invest Dermatol. 2006;126(6):1251–1255
  43. Lober BA, Fenske NA. Optimum treatment strategies for actinic keratosis (intraepidermal squamous cell carcinoma). Am J Clin Dermatol. 2004;5(6):395–401
  44. Ormrod D, Jarvis B. Topical aminolevulinic acid HCl photodynamic therapy. Am J Clin Dermatol. 2000;1(2):133–139[discussion 140–1]
  45. Piacquadio DJ, Chen DM, Farber HF, et al. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials. Arch Dermatol. 2004;140(1):41–46
  46. Kurwa HA, Barlow RJ. The role of photodynamic therapy in dermatology. Clin Exp Dermatol. 1999;24(3):143–148
  47. Freeman M, Vinciullo C, Francis D, et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat. 2003;14(2):99–106
  48. Szeimies RM, Landthaler M, Karrer S. Non-oncologic indications for ALA-PDT. J Dermatolog Treat. 2002;13 Suppl. 1:S13–S18
  49. Pariser DM, Lowe NJ, Stewart DM, et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol. 2003;48(2):227–232
  50. Stender IM, Wulf HC. Photodynamic therapy with 5-aminolevulinic acid in the treatment of actinic cheilitis. Br J Dermatol. 1996;135(3):454–456
  51. Alexiades-Armenakas MR, Geronemus RG. Laser-mediated photodynamic therapy of actinic cheilitis. J Drugs Dermatol. 2004;3(5):548–551
  52. Morton CA. Topical photodynamic therapy for Bowen's disease. Australas J Dermatol. 2005;46 Suppl.:S11;[discussion S23-5]
  53. Morton CA, Whitehurst C, Moore JV, et al. Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy [In Process Citation]. Br J Dermatol. 2000;143(4):767–772
  54. Morton CA, Whitehurst C, McColl JH, et al. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. Arch Dermatol. 2001;137(3):319–324
  55. Salim A, Leman JA, McColl JH, et al. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol. 2003;148(3):539–543
  56. Jones CM, Mang T, Cooper M, et al. Photodynamic therapy in the treatment of Bowen's disease. J Am Acad Dermatol. 1992;27(6 Pt 1):979–982
  57. Buchanan RB, Carruth JA, McKenzie AL, et al. Photodynamic therapy in the treatment of malignant tumours of the skin and head and neck. Eur J Surg Oncol. 1989;15(5):400–406
  58. Robinson PJ, Carruth JA, Fairris GM. Photodynamic therapy: a better treatment for widespread Bowen's disease. Br J Dermatol. 1988;119(1):59–61
  59. Lui H, Hobbs L, Tope WD, et al. Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes: two-year results evaluating tumor response and cosmetic outcomes. Arch Dermatol. 2004;140(1):26–32
  60. Szeimies RM, Morton CA, Sidoroff A, et al. Photodynamic therapy for non-melanoma skin cancer. Acta Derm Venereol. 2005;85(6):483–490
  61. Brown SB, Brown EA, Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 2004;5(8):497–508
  62. Morton CA, Brown SB, Collins S, et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol. 2002;146(4):552–567
  63. Haller JC, Cairnduff F, Slack G, et al. Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy. Br J Dermatol. 2000;143(6):1270–1275
  64. Clark C, Bryden A, Dawe R, et al. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmunol Photomed. 2003;19(3):134–141
  65. Wang I, Bendsoe N, Klinteberg CA, et al. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol. 2001;144(4):832–840
  66. Horn M, Wolf P, Wulf HC, et al. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol. 2003;149(6):1242–1249
  67. Basset-Seguin N, Ibbotson S, Emtestam L. Photodynamic therapy using Metvix is as efficacious as cryotherapy in BCC, with better cosmetic results. J Eur Acad Dermatol Venereol. 2001;15:226
  68. Soler AM, Warloe T, Tausjo J, et al. Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study. Acta Derm Venereol. 1999;79(3):204–206
  69. Thissen MR, Schroeter CA, Neumann HA. Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br J Dermatol. 2000;142(2):338–339
  70. Photodynamic therapy of human skin malignancies and laser-induced fluorescence diagnostics utilizing Photofrin and delta-aminolevulinic acid. In:  Svanberg K,  Andersson T,  Killander D,  Spinelli P,  Fante MD,  Marchesini R editor. Photodynamic therapy and biomedical lasers. Amsterdam: Elsevier Science Publishers B.V.; 1992;p. 436–440
  71. Kormeili T, Yamauchi PS, Lowe NJ. Topical photodynamic therapy in clinical dermatology. Br J Dermatol. 2004;150(6):1061–1069
  72. Choudry K, Brooke RC, Farrar W, et al. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy. Br J Dermatol. 2003;149(1):124–130
  73. Peng Q, Berg K, Moan J, et al. 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol. 1997;65(2):235–251
  74. Zeitouni NC, Oseroff AR, Shieh S. Photodynamic therapy for nonmelanoma skin cancers. Current review and update. Mol Immunol. 2003;39(17–18):1133–1136
  75. Wilson BD, Mang TS, Cooper M, et al. Use of photodynamic therapy for the treatment of extensive basal cell carcinomas. Facial Plast Surg. 1989;6(3):185–189
  76. Hintschich C, Feyh J, Beyer-Machule C, et al. Photodynamic laser therapy of basal-cell carcinoma of the lid. Ger J Ophthalmol. 1993;2(4–5):212–217
  77. Kubler AC, de Carpentier J, Hopper C, et al. Treatment of squamous cell carcinoma of the lip using Foscan-mediated photodynamic therapy. Int J Oral Maxillofac Surg. 2001;30(6):504–509
  78. Kubler AC, Haase T, Staff C, et al. Photodynamic therapy of primary nonmelanomatous skin tumours of the head and neck. Lasers Surg Med. 1999;25(1):60–68
  79. Chan AL, Juarez M, Allen R, et al. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces. Photodermatol Photoimmunol Photomed. 2005;21(2):72–78
  80. Itkin A, Gilchrest BA. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome. Dermatol Surg. 2004;30(7):1054–1061
  81. Oseroff AR, Shieh S, Frawley NP, et al. Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapy. Arch Dermatol. 2005;141(1):60–67
  82. Madan V, Locanster J, Allan D, et al. Systemic photodynamic therapy with Photofrin for naevoid basal cell carcinoma syndrome-A pilot study. Photodiagn Photodyn Ther. 2005;2(4):273–281
  83. Cairnduff F, Stringer MR, Hudson EJ, et al. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. Br J Cancer. 1994;69(3):605–608
  84. Pennington DG, Waner M, Knox A. Photodynamic therapy for multiple skin cancers. Plast Reconstr Surg. 1988;82(6):1067–1071
  85. Petrelli NJ, Cebollero JA, Rodriguez-Bigas M, et al. Photodynamic therapy in the management of neoplasms of the perianal skin. Arch Surg. 1992;127(12):1436–1438
  86. Kendall CA, Morton CA. Photodynamic therapy for the treatment of skin disease. Technol Cancer Res Treat. 2003;2(4):283–288
  87. Boehncke WH, Kaufmann R. Photodynamic therapy at the threshold of clinical use in disseminated dermatoses. Hautarzt. 1996;47(11):825–831
  88. Zeitouni NC, Shieh S, Oseroff AR. Laser and photodynamic therapy in the management of cutaneous malignancies. Clin Dermatol. 2001;19(3):328–338
  89. Edstrom DW, Porwit A, Ros AM. Photodynamic therapy with topical 5-aminolevulinic acid for mycosis fungoides: clinical and histological response. Acta Derm Venereol. 2001;81(3):184–188
  90. Leman JA, Dick DC, Morton CA. Topical 5-ALA photodynamic therapy for the treatment of cutaneous T-cell lymphoma. Clin Exp Dermatol. 2002;27(6):516–518
  91. Coors EA, von den Driesch P. Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma. J Am Acad Dermatol. 2004;50(3):363–367
  92. Bernstein ZP, Wilson BD, Oseroff AR, et al. Photofrin photodynamic therapy for treatment of AIDS-related cutaneous Kaposi's sarcoma. Aids. 1999;13(13):1697–1704
  93. Hebeda KM, Huizing MT, Brouwer PA, et al. Photodynamic therapy in AIDS-related cutaneous Kaposi's sarcoma. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10(1):61–70
  94. Abels C. Targeting of the vascular system of solid tumours by photodynamic therapy (PDT). Photochem Photobiol Sci. 2004;3(8):765–771
  95. Dauda MM, Shehu SM. Malignant melanoma: a review. Niger Postgrad Med J. 2005;12(2):125–130
  96. Rodriguez J, Nonaka D, Kuhn E, et al. Combined high-grade basal cell carcinoma and malignant melanoma of the skin (“malignant basomelanocytic tumor” report of two cases and review of the literature. Am J Dermatopathol. 2005;27(4):314–318
  97. Sheleg SV, Zhavrid EA, Khodina TV, et al. Photodynamic therapy with chlorin e(6) for skin metastases of melanoma. Photodermatol Photoimmunol Photomed. 2004;20(1):21–26
  98. Saczko J, Kulbacka J, Chwilkowska A, et al. The influence of photodynamic therapy on apoptosis in human melanoma cell line. Folia Histochem Cytobiol. 2005;43(3):129–132
  99. Allison RR, Sibata C, Mang TS, et al. Photodynamic therapy for chest wall recurrence from breast cancer. Photodiagn Photodyn Ther. 2004;1(2):157–171
  100. Schuh M, Nseyo UO, Potter WR, et al. Photodynamic therapy for palliation of locally recurrent breast carcinoma. J Clin Oncol. 1987;5(11):1766–1770
  101. Khan SA, Dougherty TJ, Mang TS. An evaluation of photodynamic therapy in the management of cutaneous metastases of breast cancer. Eur J Cancer. 1993;29A(12):1686–1690
  102. Taber SW, Fingar VH, Wieman TJ. Photodynamic therapy for palliation of chest wall recurrence in patients with breast cancer. J Surg Oncol. 1998;68(4):209–214
  103. Allison R, Mang T, Hewson G, et al. Photodynamic therapy for chest wall progression from breast carcinoma is an underutilized treatment modality. Cancer. 2001;91(1):1–8
  104. Cuenca RE, Allison RR, Sibata C, et al. Breast cancer with chest wall progression: treatment with photodynamic therapy. Ann Surg Oncol. 2004;11(3):322–327
  105. Wyss P, Schwarz V, Dobler-Girdziunaite D, et al. Photodynamic therapy of locoregional breast cancer recurrences using a chlorin-type photosensitizer. Int J Cancer. 2001;93(5):720–724
  106. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B. 1990;6(1–2):143–148
  107. Kaplan MJ, Somers RG, Greenberg RH, et al. Photodynamic therapy in the management of metastatic cutaneous adenocarcinomas: case reports from phase 1/2 studies using tin ethyl etiopurpurin (SnET2). J Surg Oncol. 1998;67(2):121–125

PII: S1572-1000(06)00087-1

doi: 10.1016/j.pdpdt.2006.05.002

Photodiagnosis and Photodynamic Therapy
Volume 3, Issue 4 , Pages 214-226 , December 2006

Article Tools